Immunogenicity of highly conserved recombinant vacj outer membrane lipoprotein of pasteurella multocida

Vaccine

Volumn 32, Issue 2, 2014, Pages 290-296

  Shivachandra, Sathish Bhadravati ^a   Kumar, Abhinendra ^a   Yogisharadhya, Revanaiah ^a   Viswas, K N ^a  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

Author keywords

Immunogenecity; Mouse model; Outer membrane protein; Pasteurella multocida; Protective efficacy; Recombinant VacJ lipoprotein

Indexed keywords

FREUND ADJUVANT; HYBRID PROTEIN; LIPOPROTEIN; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN VACJ; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG PURIFICATION; ESCHERICHIA COLI; GENE EXPRESSION; GENE SEQUENCE; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; MOLECULAR CLONING; MOUSE; NONHUMAN; PASTEURELLA MULTOCIDA; PRIORITY JOURNAL; PROTEIN PURIFICATION; WESTERN BLOTTING;

IMMUNOGENECITY; MOUSE MODEL; OUTER MEMBRANE PROTEIN; PASTEURELLA MULTOCIDA; PROTECTIVE EFFICACY; RECOMBINANT VACJ LIPOPROTEIN;

ADJUVANTS, IMMUNOLOGIC; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; CLONING, MOLECULAR; IMMUNITY, HUMORAL; IMMUNOGLOBULIN G; LIPOPROTEINS; MICE; MOLECULAR SEQUENCE DATA; PASTEURELLA INFECTIONS; PASTEURELLA MULTOCIDA; RECOMBINANT FUSION PROTEINS;

EID: 84890559319     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.10.075     Document Type: Article

References (41)

1. Hunt M.L., Adler B., Townsend K.M. The molecular biology of Pasteurella multocida. Vet Microbiol 2000, 72:3-25.
2. Harper M., Boyce J.D., Adler B. Pasteurella multocida pathogenesis: 125 years after Pasteur. FEMS Microbiol Lett 2006, 265:1-10.
3. Shivachandra S.B., Viswas K.N., Kumar A.A. A review of haemorrhagic septicaemia in cattle and buffalo. Anim Health Res Rev 2011, 12:67-82.
4. Wilson B.A., Ho M. Pasteurella multocida: from zoonosis to cellular microbiology. Clin Microbiol Rev 2013, 26:631-655.
5. Kumar A.A., Shivachandra S.B., Biswas A., Singh V.P., Singh V.P., Srivastava S.K. Prevalent serotypes of Pasteurella multocida isolated from different animal and avian species in India. Vet Res Commun 2004, 28:657-667.
6. Biswas A., Shivachandra S.B., Saxena M.K., Kumar A.A., Singh V.P., Srivastava S.K. Molecular variability among strains of Pasteurella multocida isolated from an outbreak of haemorrhagic septicaemia in India. Vet Res Commun 2004, 28:287-298.
7. Verma R., Jaiswal T.N. Haemorrhagic septicaemia vaccines. Vaccine 1998, 16:1184-1190.
8. Shivachandra S.B., Kumar A.A., Amaranath J., Joseph S., Srivastava S.K., Chaudhuri P. Cloning and characterization of tbpA gene encoding transferrin binding protein (TbpA) from Pasteurella multocida B:2 (strain P52). Vet Res Commun 2005, 29:537-542.
9. Hatfaludi T., Al-Hasani K., Boyce J.D., Adler B. Outer membrane proteins of Pasteurella multocida. Vet Microbiol 2010, 144:1-17.
10. Hatfaludi T., Al-Hasani K., Gong L., Boyce J.D., Ford M., Wilkie I.W., et al. Screening of 71 P. multocida proteins for protective efficacy in a fowl cholera infection model and characterization of the protective antigen PlpE. PLoS ONE 2012, 7:e39973.
11. Shivachandra S.B., Yogisharadhya R., Ahuja A., Bhanuprakash V. Expression and purification of recombinant type IV fimbrial subunit protein of Pasteurella multocida serogroup B:2 in Escherichia coli. Res Vet Sci 2012, 93:1128-1131.
12. Shivachandra S.B., Kumar A., Yogisharadhya R., Ramakrishnan M.A., Viswas K.N. Carboxyl terminus heterogeneity of type IV fimbrial subunit protein of Pasteurella multocida isolates. Vet Res Commun 2013, 37:269-275.
13. E-Komon T., Burchmore R., Herzyk P., Davies R. Predicting the outer membrane proteome of Pasteurella multocida based on consensus prediction enhanced by results integration and manual confirmation. BMC Bioinform 2012, 27:13-63.
14. Tabatabai L.B., Zehr E.S. Identification of five outer membrane associated proteins among cross-protective factor proteins of Pasteurella multocida. Infect Immun 2004, 72:1195-1198.
15. Rimler R.B. Purification of a cross-protective antigen from Pasteurella multocida grown in vitro and in vivo. Avian Dis 2001, 45:572-580.
16. Wu J.R., Shien J.H., Shieh H.K., Chen C.F., Chang P.C. Protective immunity conferred by recombinant Pasteurella multocida lipoprotein E (PlpE). Vaccine 2007, 25:4140-4148.
17. Champlin F.R., Shryock T.R., Patterson C.E., Austin F.W., Ryals P.E. Prevalence of a novel capsule-associated lipoprotein among Pasteurellaceae pathogenic in animals. Curr Microbiol 2002, 44:297-301.
18. Lo M., Boyce J.D., Wilkie I.W., Adler B. Characterization of two lipoproteins in Pasteurella multocida. Microbes Infect 2004, 6:58-67.
19. Kasten R.W., Wakenell P.S., Ahmad S., Yilma T.D., Hirsh D.C. Lack of protection against avian cholera by vaccination with recombinant P6-like protein from Pasteurella multocida. Avian Dis 1997, 41:972-976.
20. Boyce J.D., Cullen P.A., Nguyen V., Wilkie I., Adler B. Analysis of the Pasteurella multocida outer membrane sub-proteome and its response to the in vivo environment of the natural host. Proteomics 2006, 6:870-880.
21. Al-Hasani K., Boyce J., McCarl V.P., Bottomley S., Wilkie I., Adler B. Identification of novel immunogens in Pasteurella multocida. Microb Cell Factories 2007, 6:3.
22. Suzuki T., Murai T., Fukuda I., Tobe T., Yoshikawa M., Sasakawa C. Identification and characterization of a chromosomal virulence gene, vacJ, required for intercellular spreading of Shigella flexneri. Mol Microbiol 1994, 11(1):31-41.
23. Dabo S.M., Confer A., Montelongo M., York P. Wyckoff JH III. Vaccination with Pasteurella multocida recombinant OmpA induces strong but non-protective and deleterious Th2-type immune response in mice. Vaccine 2008, 12:4345-4351.
24. Reed L.J., Muench H. A simple method of estimating fifty percent endpoints. Am J Hygiene 1938, 27:493-497.
25. Townsend K.M., Frost A.J., Lee C.W., Papadimitrious J.M., Dawkins H.J. Development of PCR assays for species and type specific identification of Pasteurella multocida isolates. J Clin Microbiol 1998, 36:1096-1100.
26. Sutcliffe I.C., Harrington D.J., Hutchings M.I. A phylum level analysis reveals lipoprotein biosynthesis to be a fundamental property of bacteria. Protein Cell 2012, 3:163-170.
27. Kovacs-Simon A., Titball R.W., Michell S.L. Lipoproteins of bacterial pathogens. Infect Immun 2011, 79:548-561.
28. Nakayama H., Kurokawa K., Lee B.L. Lipoproteins in bacteria: structures and biosynthetic pathways. FEBS J 2012, 279:4247-4268.
29. Braun V., Wu H.C. Lipoproteins, structure, function, biosynthesis and model for protein export. New Compr Biochem 1994, 27:319-341.
30. Hayashi S., Wu H.C. Lipoproteins in bacteria. J Bioenerg Biomembr 1990, 22:451-471.
31. Madurawe R.D., Chase T.E., Tsao E.I., Bentley W.E. A recombinant lipoprotein antigen against Lyme disease expressed in E. coli: fermentor operating strategies for improved yield. Biotechnol Prog 2000, 16:571-576.
32. Cornelis P., Sierra J.C., Lim A., Malur A., Tungpradabkul S., Tazka H., et al. Development of new cloning vectors for the production of immunogenic outer membrane fusion proteins in Escherichia coli. Biotech 1996, 14:203-208.
33. Wu H.C., Tokunaga M. Biogenesis of lipoproteins in bacteria. Curr Top Microbiol Immunol 1986, 125:127-157.
34. Weis J.J., Ma Y., Erdile L.F. Biological activities of native and recombinant Borrelia burgdorferi outer surface protein A: dependence on lipid modification. Infect Immun 1994, 62:4632-4636.
35. Iwasaki A., Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science 2010, 327:291-295.
36. Lugade A.A., Bianchi-Smiraglia A., Pradhan V., Elkin G., Murphy T.F., Thanavala Y. Lipid motif of a bacterial antigen mediates immune responses via TLR2 signaling. PLoS ONE 2011, 6:e19781.
37. Shibaki A., Katz S.I. Induction of skewed Th1/Th2 T-cell differentiation via subcutaneous immunization with Freund's adjuvant. Exp Dermatol 2002, 11:126-134.
38. Iweala O.I., Smith D.W., Matharu K.S., Sada-Ovalle I., Nguyen D.D., Dekruyff R.H., et al. Vaccine-induced antibody isotypes are skewed by impaired CD4T cell and invariant NKT cell effector responses in MyD88-deficient mice. J Immunol 2009, 183:2252-2260.
39. 1 antibodies is modulated by adjuvants. Int Immunol 2000, 12:1733-1740.
40. Cox J.C., Coulter A.R. Adjuvants-a classification and review of their modes of action. Vaccine 1997, 15:248-256.
41. Kumar A., Yogisharadhya R., Ramakrishnan M.A., Viswas K.N., Shivachandra S.B. Structural analysis and cross-protective efficacy of recombinant 87kDa outer membrane protein (Omp87) of Pasteurella multocida serogroup B:2. Microb Pathog 2013, 65:48-56.